Article info
PDFPostScript
Letter
Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
- Correspondence to Dr Bethany Van Guelpen, Department of Radiation Sciences, Oncology, Umeå University, SE-90187 Umeå, Sweden; bethany.vanguelpen{at}umu.se
Citation
Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
Publication history
- Received January 26, 2018
- Revised February 8, 2018
- Accepted February 10, 2018
- First published February 28, 2018.
Online issue publication
July 08, 2019
Article Versions
- Previous version (30 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/